We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-5.11%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.4B
AUM Growth
-$929M
Cap. Flow
-$275M
Cap. Flow %
-2.65%
Top 10 Hldgs %
43.03%
Holding
1,068
New
166
Increased
266
Reduced
450
Closed
162

Sector Composition

Rank Sector Weight
1 Energy 50.72%
2 Financials 11.42%
3 Technology 6.62%
4 Healthcare 4.85%
5 Consumer Discretionary 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STOK icon
376
Stoke Therapeutics
STOK
$1.82B
$1.15M 0.01%
45,034
-3,317
-7% -$92.5K
NHI icon
377
National Health Investors
NHI
$3.9B
$1.14M 0.01%
21,327
+502
+2% +$31.4K
SNDX icon
378
Syndax Pharmaceuticals
SNDX
$1.84B
$1.14M 0.01%
59,593
-3,948
-6% -$65.8K
KROS icon
379
Keros Therapeutics
KROS
$199M
$1.13M 0.01%
28,599
-2,088
-7% -$74.3K
RAPT
380
DELISTED
RAPT Therapeutics
RAPT
$1.12M 0.01%
4,517
+400
+10% +$106K
TRMK icon
381
Trustmark
TRMK
$2.73B
$1.11M 0.01%
34,483
-11,548
-25% -$354K
ETR icon
382
Entergy
ETR
$54.1B
$1.11M 0.01%
22,282
-1,460
-6% -$78.1K
CPRX
383
DELISTED
Catalyst Pharmaceutical
CPRX
$1.06M 0.01%
200,400
-17,478
-8% -$95.6K
BTAI icon
384
BioXcel Therapeutics
BTAI
$26.2M
$1.04M 0.01%
2,142
+115
+6% +$50.6K
PG icon
385
Procter & Gamble
PG
$343B
$1.03M 0.01%
7,377
-3,522
-32% -$499K
MCY icon
386
Mercury Insurance
MCY
$5.94B
$1.02M 0.01%
18,359
-1,300
-7% -$77.6K
PRAX icon
387
Praxis Precision Medicines
PRAX
$9.07B
$1.02M 0.01%
3,670
-160
-4% -$43.4K
CRNX icon
388
Crinetics Pharmaceuticals
CRNX
$8.86B
$999K 0.01%
47,436
-2,080
-4% -$43.5K
VMEO
389
DELISTED
Vimeo
VMEO
$988K 0.01%
33,650
-18,000
-35% -$710K
ADAP
390
DELISTED
Adaptimmune Therapeutics
ADAP
$985K 0.01%
190,550
-14,225
-7% -$63.8K
NKE icon
391
Nike
NKE
$61.9B
$979K 0.01%
6,742
+2,289
+51% +$373K
CUBE icon
392
CubeSmart
CUBE
$9.53B
$978K 0.01%
20,175
-4,919
-20% -$248K
EL icon
393
Estee Lauder
EL
$29B
$961K 0.01%
3,204
+2,452
+326% +$801K
MPWR icon
394
Monolithic Power Systems
MPWR
$65.5B
$960K 0.01%
1,982
-531
-21% -$242K
FULT icon
395
Fulton Financial
FULT
$4.7B
$958K 0.01%
62,674
KNSA icon
396
Kiniksa Pharmaceuticals
KNSA
$4.83B
$957K 0.01%
83,983
+41,412
+97% +$539K
AKRO
397
DELISTED
Akero Therapeutics
AKRO
$955K 0.01%
42,729
-3,143
-7% -$71.1K
AAT
398
American Assets Trust
AAT
$1.49B
$922K 0.01%
24,626
ZBRA icon
399
Zebra Technologies
ZBRA
$12.4B
$914K 0.01%
1,772
-336
-16% -$187K
ANAB icon
400
AnaptysBio
ANAB
$1.6B
$912K 0.01%
33,623
-2,422
-7% -$61.5K

Similar funds

ALPS Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, ALPS Advisors held 1,068 positions worth $10.4B, down 8.2% from $11.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

ALPS Advisors's Q3 2021 filing shows 166 new, 266 increased, 450 reduced and 162 closed positions. Its largest new stake was Stem: 59,506 shares worth $28.4M. The largest sale was MPLX, an estimated $69.6M.

By sector, the portfolio is most concentrated in Energy at 51% of assets, down from 53% a quarter earlier, followed by Financials and Technology.

  • ALPS Advisors's largest Q3 2021 buy was Stem: 59,506 shares worth $28.4M.
  • ALPS Advisors added most to ENLINK MIDSTREAM, LLC in Q3 2021, an estimated $39.9M increase.
  • ALPS Advisors's biggest Q3 2021 reduction was MPLX, cutting an estimated $69.6M.
  • ALPS Advisors fully exited Universal Display in Q3 2021, selling an estimated $47.2M.
  • ALPS Advisors's ten largest holdings make up 43% of its $10.4B portfolio in Q3 2021.
  • ALPS Advisors opened 166 new positions and closed 162 in Q3 2021.
  • ALPS Advisors's portfolio value fell 8.2% quarter-over-quarter to $10.4B.

Based on ALPS Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.